ECO MEDICS CIC

Company limited by guarantee

Company Registration Number:
13573231 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2023

Period of accounts

Start date: 1 September 2022

End date: 31 August 2023

ECO MEDICS CIC

Contents of the Financial Statements

for the Period Ended 31 August 2023

Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

ECO MEDICS CIC

Balance sheet

As at 31 August 2023

Notes 2023 2022


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 252 1,587
Investments:   0 0
Total current assets: 252 1,587
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 3 ( 1,465 ) ( 1,302 )
Net current assets (liabilities): (1,213) 285
Total assets less current liabilities: (1,213) 285
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): (1,213) 285
Members' funds
Profit and loss account: (1,213) 285
Total members' funds: ( 1,213) 285

The notes form part of these financial statements

ECO MEDICS CIC

Balance sheet statements

For the year ending 31 August 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 28 August 2024
and signed on behalf of the board by:

Name: Nathan James Hudson-Peacock
Status: Director

The notes form part of these financial statements

ECO MEDICS CIC

Notes to the Financial Statements

for the Period Ended 31 August 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ECO MEDICS CIC

Notes to the Financial Statements

for the Period Ended 31 August 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 0 0

ECO MEDICS CIC

Notes to the Financial Statements

for the Period Ended 31 August 2023

3. Creditors: amounts falling due within one year note

2023 2022
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 67
Accruals and deferred income 465 735
Other creditors 1,000 500
Total 1,465 1,302

COMMUNITY INTEREST ANNUAL REPORT

ECO MEDICS CIC

Company Number: 13573231 (England and Wales)

Year Ending: 31 August 2023

Company activities and impact

Eco Medics CIC exists to tackle the climate crisis by encouraging and enabling sustainable behaviour amongst individuals who work in healthcare. Over the year August 2022 – 2023, we have had a quiet year due to the NHS and personal commitments of the 4 directors. However, despite this, we have organised several educational talks and run some sharing circle networking and wellness events. These have all been free of charge. These activities have benefited the community by providing free education to those working in healthcare, as well as interested parties and students of healthcare professionals, about climate change and sustainable healthcare. By encouraging adoption of more long-term, environmentally-friendly policies and materials use, both on an individual level and at policy level within the healthcare industry, this will lead to more action to fight and adapt to the climate crisis.

Consultation with stakeholders

The company’s stakeholders are people, primarily healthcare professionals, who have an interest in the climate crisis, sustainable healthcare, and the role of healthcare professionals and the healthcare industry in the prevention of and adaptation to the climate crisis. We ask event attendees to fill in a feedback form. Due to the relatively small number of activities this year, we haven't consulted stakeholders for any specific feedback beyond the aforementioned.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
28 August 2024

And signed on behalf of the board by:
Name: Nathan James Hudson-Peacock
Status: Director